Podium to Practice: EHA 2026 – Leukemia: Quizartinib vs Midostaurin in FLT3-ITD AML
OR
Studies / Trials Discussed
S133 – INTENSIVE CHEMOTHERAPY IN COMBINATION WITH QUIZARTINIB VERSUS MIDOSTAURIN FOR FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA: A MULTICENTER COHORT STUDY
Chair
Explore more from your favourite experts – click their name to access their entire library of content.
Studies/trials discussed:
S133 – INTENSIVE CHEMOTHERAPY IN COMBINATION WITH QUIZARTINIB VERSUS MIDOSTAURIN FOR FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA: A MULTICENTER COHORT STUDY
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.